Skip to main content

Buchanan Lucas W.'s Form 4 filing

Silk Road Medical Inc (SILK) · filed Jul 29, 2021

Accession no.
0001593968-21-001917
Filed
Jul 29, 2021
Trade date
Jul 27-28, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $449.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Buchanan Lucas W.CIK 0001769830Officer (COO/CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 27, 2021Common StockMOption exerciseAcquired+3,000$1.60+$4,800189,192Direct
Jul 28, 2021Common StockMOption exerciseAcquired+3,595$20.00+$71,900192,787Direct
Jul 28, 2021Common StockSSaleDisposed−3,595$44.91F2−$161,451.45189,192Direct
Jul 28, 2021Common StockMOption exerciseAcquired+4,021$30.93+$124,369.53193,213Direct
Jul 28, 2021Common StockSSaleDisposed−4,021$44.91F2−$180,583.11189,192Direct
Jul 28, 2021Common StockSSaleDisposed−2,384$44.91F2−$107,065.44186,808Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 27, 2021Common StockMOption exerciseDisposed−3,000$0.00$0135,409Direct
Jul 28, 2021Common StockMOption exerciseDisposed−3,595$0.00$045,448Direct
Jul 28, 2021Common StockMOption exerciseDisposed−4,021$0.00$028,154Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at price ranging from $43.97 to $46.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)